|Form of Medicine
Halaven(Eribulin) is an anti-cancer ("antineoplastic" or "cytotoxic") chemotherapy drug. This medication is classified as a "non-taxane microtubule inhibitor". (For more detail, see “How Eribulin Works” below)
What Eribulin Is Used For:
Eribulin is used for the treatment of patients with metastatic breast cancer.
Note: If a drug has been approved for one use, physicians may elect to use this same drug for other problems if they believe it may be helpful.
How Eribulin Is Given:
The amount of eribulin that you will receive depends on many factors, including your height and weight, your general health or other health problems, and the type of cancer or condition you have. Your doctor will determine your exact dosage and schedule.
Side effects of Eribulin:
Important things to remember about the side effects of eribulin:
The following side effects are common (occurring in greater than 30%) for patients taking eribulin:
These are less common (occurring in 10-29%) side effects for patients receiving eribulin:
Not all side effects are listed above. Side effects that are rare -- occurring in less than about 10 percent of patients -- are not listed here. But you should always inform your health care provider if you experience any unusual symptoms.
Note: We strongly encourage you to talk with your health care professional about your specific medical condition and treatments. The information contained in this website is meant to be helpful and educational, but is not a substitute for medical advice.
|Dosage Form (If Applicable)